VEGF Paradoxically Reduces Cerebral Blood Flow in Alzheimer’s Disease Mice

Vascular dysfunction plays a critical role in the development of Alzheimer’s disease. Cerebral blood flow reductions of 10% to 25% present early in disease pathogenesis. Vascular Endothelial Growth Factor-A (VEGF-A) drives angiogenesis, which typically addresses blood flow reductions and global hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Muhammad, Bracko, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298729/
https://www.ncbi.nlm.nih.gov/pubmed/35873789
http://dx.doi.org/10.1177/26331055221109254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298729/
https://www.ncbi.nlm.nih.gov/pubmed/35873789
http://dx.doi.org/10.1177/26331055221109254

Ejemplares similares